Cargando…

ATG5 as biomarker for early detection of malignant mesothelioma

OBJECTIVES: Malignant pleural mesothelioma (MPM) is an aggressive disease with grim prognosis due to lack of effective treatment options. Disease prediction in association with early diagnosis may both contribute to improved MPM survival. Inflammation and autophagy are two processes associated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomasetti, Marco, Monaco, Federica, Strogovets, Olga, Volpini, Luca, Valentino, Matteo, Amati, Monica, Neuzil, Jiri, Santarelli, Lory
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127310/ https://www.ncbi.nlm.nih.gov/pubmed/37095543 http://dx.doi.org/10.1186/s13104-023-06330-1

Ejemplares similares

Epigenetic Regulation of miRNA Expression in Malignant Mesothelioma: miRNAs as Biomarkers of Early Diagnosis and Therapy
por: Tomasetti, Marco, et al.
Publicado: (2019)

Biomarkers for Early Detection of Malignant Mesothelioma: Diagnostic and Therapeutic Application
por: Tomasetti, Marco, et al.
Publicado: (2010)

MicroRNA in Metabolic Re-Programming and Their Role in Tumorigenesis
por: Tomasetti, Marco, et al.
Publicado: (2016)

MicroRNA-126 induces autophagy by altering cell metabolism in malignant mesothelioma
por: Tomasetti, Marco, et al.
Publicado: (2016)

Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression
por: Grimolizzi, Franco, et al.
Publicado: (2017)

Association of MiR-126 with Soluble Mesothelin-Related Peptides, a Marker for Malignant Mesothelioma
por: Santarelli, Lory, et al.
Publicado: (2011)

BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma
por: Murrone, Albero, et al.
Publicado: (2021)

Exosome-derived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapy
por: Tomasetti, Marco, et al.
Publicado: (2017)

Peripheral Skin Temperature and Circadian Biological Clock in Shift Nurses after a Day off
por: Bracci, Massimo, et al.
Publicado: (2016)

MiRNome analysis identifying miR‐205 and miR‐449a as biomarkers of disease progression in intestinal‐type sinonasal adenocarcinoma
por: Re, Massimo, et al.
Publicado: (2021)

MiR-126 in intestinal-type sinonasal adenocarcinomas: exosomal transfer of MiR-126 promotes anti-tumour responses
por: Tomasetti, Marco, et al.
Publicado: (2018)

Force-feeding malignant mesothelioma stem-cell like with exosome-delivered miR-126 induces tumour cell killing
por: Monaco, Federica, et al.
Publicado: (2022)

Occupational Styrene Exposure Induces Stress-Responsive Genes Involved in Cytoprotective and Cytotoxic Activities
por: Strafella, Elisabetta, et al.
Publicado: (2013)

α-Tocopheryl succinate and TRAIL selectively synergise in induction of apoptosis in human malignant mesothelioma cells
por: Tomasetti, M, et al.
Publicado: (2004)

Circadian Modulation of 8-Oxoguanine DNA Damage Repair
por: Manzella, Nicola, et al.
Publicado: (2015)

Malignant mesothelioma in construction workers: the Apulia regional mesothelioma register, Southern Italy
por: Vimercati, L., et al.
Publicado: (2019)

Sub-apoptotic dosages of pro-oxidant vitamin cocktails sensitize human melanoma cells to NK cell lysis
por: Tremante, Elisa, et al.
Publicado: (2015)

Determinants of plasma calretinin in patients with malignant pleural mesothelioma
por: Lehnert, Martin, et al.
Publicado: (2020)

A molecular phenotypic map of malignant pleural mesothelioma
por: Di Genova, Alex, et al.
Publicado: (2023)

Alpha-Tocopheryl Succinate Inhibits Autophagic Survival of Prostate Cancer Cells Induced by Vitamin K3 and Ascorbate to Trigger Cell Death
por: Tomasetti, Marco, et al.
Publicado: (2012)

α-Tocopheryl succinate promotes selective cell death induced by vitamin K3 in combination with ascorbate
por: Tomasetti, M, et al.
Publicado: (2010)

Discovery of new biomarkers for malignant mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2015)

Circulating biomarkers in malignant pleural mesothelioma
por: Viscardi, Giuseppe, et al.
Publicado: (2020)

Evaluation of prognostic histological parameters proposed for pleural mesothelioma in diffuse malignant peritoneal mesothelioma. A short report
por: Pezzuto, Federica, et al.
Publicado: (2021)

Characterisation of Mesothelioma-Initiating Cells and Their Susceptibility to Anti-Cancer Agents
por: Pasdar, Elham Alizadeh, et al.
Publicado: (2015)

Immunotherapy with immune checkpoint inhibitors and predictive biomarkers in malignant mesothelioma: Work still in progress
por: Perrino, Matteo, et al.
Publicado: (2023)

Correction: Characterisation of Mesothelioma-Initiating Cells and Their Susceptibility to Anti-Cancer Agents
por: Pasdar, Elham Alizadeh, et al.
Publicado: (2016)

Serum Calretinin as a Biomarker in Malignant Mesothelioma
por: Zupanc, Cita, et al.
Publicado: (2021)

Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma
por: Yang, Haitang, et al.
Publicado: (2020)

Circulating Epigenetic Biomarkers in Malignant Pleural Mesothelioma: State of the Art and critical Evaluation
por: Ferrari, Luca, et al.
Publicado: (2020)

Malignant mesothelioma
por: Ruffié, P, et al.
Publicado: (2001)

Malignant mesothelioma
por: Moore, Alastair J, et al.
Publicado: (2008)

Malignant mesothelioma
por: Ahmed, Ishtiaq, et al.
Publicado: (2013)

Malignant Mesothelioma
por: Pouliquen, Daniel L., et al.
Publicado: (2021)

Biomarkers for Predicting Malignant Pleural Mesothelioma in a Mexican Population
por: Aguilar-Madrid, Guadalupe, et al.
Publicado: (2018)

Identification of Overexpressed Genes in Malignant Pleural Mesothelioma
por: Morani, Federica, et al.
Publicado: (2021)

Are circulating microRNAs suitable for the early detection of malignant mesothelioma? Results from a nested case–control study
por: Weber, Daniel Gilbert, et al.
Publicado: (2019)

Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma
por: Kovac, Viljem, et al.
Publicado: (2015)

Matrix Metalloproteinases Polymorphisms as Prognostic Biomarkers in Malignant Pleural Mesothelioma
por: Štrbac, Danijela, et al.
Publicado: (2017)

Biomarkers for Malignant Pleural Mesothelioma—A Novel View on Inflammation
por: Vogl, Melanie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k471idjvp1kgq1vdc1i351fae5